These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 31899508)

  • 1. LncRNA DLGAP1-AS2 modulates glioma development by up-regulating YAP1 expression.
    Miao W; Li N; Gu B; Yi G; Su Z; Cheng H
    J Biochem; 2020 Apr; 167(4):411-418. PubMed ID: 31899508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA DLGAP1-AS2 regulates miR-503/cyclin D1 to promote cell proliferation in non-small cell lung cancer.
    Wang L; Tang L; Ge T; Zhu F; Liu D; Guo H; Qian P; Xu N
    BMC Pulm Med; 2021 Aug; 21(1):277. PubMed ID: 34454450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DLGAP1-AS2 promotes estrogen receptor signalling and confers tamoxifen resistance in breast cancer.
    Liang X; Zhao Y; Fang Z; Shao N; Zhai D; Zhang M; Yu L; Shi Y
    Mol Biol Rep; 2022 May; 49(5):3939-3947. PubMed ID: 35449318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long Non-coding RNA DLGAP1-AS1 and DLGAP1-AS2: Two Novel Oncogenes in Multiple Cancers.
    Zhao F; Tan F; Tang L; Du Z; Chen X; Yang Y; Zhou G; Yuan C
    Curr Med Chem; 2023; 30(25):2822-2834. PubMed ID: 36121088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long noncoding RNA DLGAP1-AS1 promotes the progression of glioma by regulating the miR-1297/EZH2 axis.
    Liu L; Li X; Shi Y; Chen H
    Aging (Albany NY); 2021 Apr; 13(8):12129-12142. PubMed ID: 33901010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncRNA DLGAP1-AS2 overexpression associates with gastric tumorigenesis: a promising diagnostic and therapeutic target.
    Soltani R; Amini M; Mazaheri Moghaddam M; Jebelli A; Ahmadiyan S; Bidar N; Baradaran B; MotieGhader H; Asadi M; Mokhtarzadeh A
    Mol Biol Rep; 2022 Jul; 49(7):6817-6826. PubMed ID: 34981339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The long noncoding RNA DLGAP1-AS2 facilitates cholangiocarcinoma progression via miR-505 and GALNT10.
    Liu Z; Pan L; Yan X; Duan X
    FEBS Open Bio; 2021 Feb; 11(2):413-422. PubMed ID: 33301605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long noncoding RNA kcna3 inhibits the progression of colorectal carcinoma through down-regulating YAP1 expression.
    Zhong X; Lü M; Wan J; Zhou T; Qin B
    Biomed Pharmacother; 2018 Nov; 107():382-389. PubMed ID: 30099342
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The knockdown of lncRNA DLGAP1-AS2 suppresses osteosarcoma progression by inhibiting aerobic glycolysis via the miR-451a/HK2 axis.
    Zheng C; Li R; Zheng S; Fang H; Xu M; Zhong L
    Cancer Sci; 2023 Dec; 114(12):4747-4762. PubMed ID: 37817462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DLGAP1-AS2 promotes human colorectal cancer progression through trans-activation of Myc.
    Ren C; Han H; Pan J; Chang Q; Wang W; Guo X; Bian J
    Mamm Genome; 2022 Dec; 33(4):672-683. PubMed ID: 36222892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LncRNA NNT-AS1 promotes non-small cell lung cancer progression through regulating miR-22-3p/YAP1 axis.
    He W; Zhang Y; Xia S
    Thorac Cancer; 2020 Mar; 11(3):549-560. PubMed ID: 31923353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. lncRNA CTBP1-AS2 promotes proliferation and migration of glioma by modulating miR-370-3p-Wnt7a-mediated epithelial-mesenchymal transition.
    Li Y; Zong J; Zhao C
    Biochem Cell Biol; 2020 Dec; 98(6):661-668. PubMed ID: 33150795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. METTL3-induced DLGAP1-AS2 promotes non-small cell lung cancer tumorigenesis through m
    Zhang Q; Zhang Y; Chen H; Sun LN; Zhang B; Yue DS; Wang CL; Zhang ZF
    Cell Cycle; 2022 Dec; 21(24):2602-2614. PubMed ID: 35972892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long non‑coding RNA LINC00473/miR‑195‑5p promotes glioma progression via YAP1‑TEAD1‑Hippo signaling.
    Wang X; Li XD; Fu Z; Zhou Y; Huang X; Jiang X
    Int J Oncol; 2020 Feb; 56(2):508-521. PubMed ID: 31894297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long noncoding RNA DLGAP1-AS2 facilitates Wnt1 transcription through physically interacting with Six3 and drives the malignancy of gastric cancer.
    Lu J; Xu Y; Xie W; Tang Y; Zhang H; Wang B; Mao J; Rui T; Jiang P; Zhang W
    Cell Death Discov; 2021 Sep; 7(1):255. PubMed ID: 34545072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long noncoding RNA DLGAP1-AS2 promotes tumorigenesis and metastasis by regulating the Trim21/ELOA/LHPP axis in colorectal cancer.
    Wang X; Cheng H; Zhao J; Li J; Chen Y; Cui K; Tian L; Zhang J; Li C; Sun S; Feng Y; Yao S; Bian Z; Huang S; Fei B; Huang Z
    Mol Cancer; 2022 Nov; 21(1):210. PubMed ID: 36376892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA NFIA-AS2 promotes glioma progression through modulating the miR-655-3p/ZFX axis.
    Xin J; Zhao YH; Zhang XY; Tian LQ
    Hum Cell; 2020 Oct; 33(4):1273-1280. PubMed ID: 32779154
    [TBL] [Abstract][Full Text] [Related]  

  • 18. YAP1 enhances cell proliferation, migration, and invasion of gastric cancer in vitro and in vivo.
    Sun D; Li X; He Y; Li W; Wang Y; Wang H; Jiang S; Xin Y
    Oncotarget; 2016 Dec; 7(49):81062-81076. PubMed ID: 27835600
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA LINC00899 promotes progression of acute myeloid leukaemia by modulating miR-744-3p/YY1 signalling.
    Dong X; Xu X; Guan Y
    Cell Biochem Funct; 2020 Oct; 38(7):955-964. PubMed ID: 32157707
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long non-coding RNA PICSAR knockdown inhibits the progression of cutaneous squamous cell carcinoma by regulating miR-125b/YAP1 axis.
    Lu X; Gan Q; Gan C; Zheng Y; Cai B; Li X; Li D; Yin G
    Life Sci; 2021 Jun; 274():118303. PubMed ID: 32841663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.